402 related articles for article (PubMed ID: 10517740)
1. Ticlopidine and clopidogrel.
Quinn MJ; Fitzgerald DJ
Circulation; 1999 Oct; 100(15):1667-72. PubMed ID: 10517740
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Savi P; Herbert JM
Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
[TBL] [Abstract][Full Text] [Related]
3. Platelet P2 receptors: old and new targets for antithrombotic drugs.
Cattaneo M
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):45-55. PubMed ID: 17187456
[TBL] [Abstract][Full Text] [Related]
4. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments.
Kam PC; Nethery CM
Anaesthesia; 2003 Jan; 58(1):28-35. PubMed ID: 12492666
[TBL] [Abstract][Full Text] [Related]
5. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
Maree AO; Fitzgerald DJ
Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
[No Abstract] [Full Text] [Related]
6. The role of clopidogrel in the management of acute coronary syndromes.
Wodlinger AM; Pieper JA
Clin Ther; 2003 Aug; 25(8):2155-81. PubMed ID: 14512126
[TBL] [Abstract][Full Text] [Related]
7. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
Moussa I; Oetgen M; Roubin G; Colombo A; Wang X; Iyer S; Maida R; Collins M; Kreps E; Moses JW
Circulation; 1999 May; 99(18):2364-6. PubMed ID: 10318654
[TBL] [Abstract][Full Text] [Related]
9. Summaries for patients. Is it cost-effective to treat high-risk cardiac patients with clopidogrel plus aspirin as opposed to aspirin alone?
Ann Intern Med; 2005 Feb; 142(4):I53. PubMed ID: 15710954
[No Abstract] [Full Text] [Related]
10. A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone.
Schleinitz MD; Heidenreich PA
Ann Intern Med; 2005 Feb; 142(4):251-9. PubMed ID: 15710958
[TBL] [Abstract][Full Text] [Related]
11. The thienopyridines in coronary artery disease.
Berger PB
Curr Cardiol Rep; 1999 Sep; 1(3):192-8. PubMed ID: 10980841
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel and risk for acute coronary events.
Mood GR; Bhatt DL
Curr Atheroscler Rep; 2007 Nov; 9(5):401-8. PubMed ID: 18001624
[TBL] [Abstract][Full Text] [Related]
13. Aspirin, ticlopidine, and clopidogrel in acute coronary syndromes: underused treatments could save thousands of lives.
Tan WA; Moliterno DJ
Cleve Clin J Med; 1999; 66(10):615-8, 621-4, 627-8. PubMed ID: 10598366
[TBL] [Abstract][Full Text] [Related]
14. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
15. [Thienopyridines in the treatment and prevention of cardiovascular diseases. III. therapeutic application of clopidogrel as monotherapy (without acetylsalicylic acid)].
Preobrazhenskiĭ DV; Sidorenko BA; Batyraliev TA; Vural A; Islek M; Avsar O; Fettser DV
Kardiologiia; 2009; 49(12):63-7. PubMed ID: 20038285
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and clopidogrel: a sweeping combination in cardiology.
Manolis AS; Tzeis S; Andrikopoulos G; Koulouris S; Melita H
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):203-19. PubMed ID: 15974885
[TBL] [Abstract][Full Text] [Related]
17. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
Valentine N; Van de Laar FA; van Driel ML
Cochrane Database Syst Rev; 2012 Nov; 11():CD005449. PubMed ID: 23152231
[TBL] [Abstract][Full Text] [Related]
18. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
Mehta SR; Yusuf S;
Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
[TBL] [Abstract][Full Text] [Related]
19. [Optimal platelet inhibition therapy in unstable angina pectoris and after coronary interventions].
Niessner A; Niessner H; Huber K
Herz; 2001 Apr; 26 Suppl 1():36-41. PubMed ID: 11349625
[TBL] [Abstract][Full Text] [Related]
20. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
Hankey GJ; Sudlow CL; Dunbabin DW
Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
